Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and …

VP Harjola, A Mebazaa, J Čelutkienė… - European journal of …, 2016 - Wiley Online Library
Acute right ventricular (RV) failure is a complex clinical syndrome that results from many
causes. Research efforts have disproportionately focused on the failing left ventricle, but …

The right ventricle in pulmonary arterial hypertension

R Naeije, A Manes - European respiratory review, 2014 - Eur Respiratory Soc
Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. In early-stage PAH,
the right ventricle tends to remain adapted to afterload with increased contractility and little …

Right ventricular adaptation and failure in pulmonary arterial hypertension

JJ Ryan, J Huston, S Kutty, ND Hatton… - Canadian Journal of …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is an obstructive pulmonary vasculopathy,
characterized by excess proliferation, apoptosis resistance, inflammation, fibrosis, and …

[HTML][HTML] Pathophysiology and new advances in pulmonary hypertension

S Bousseau, RS Fais, S Gu, A Frump, T Lahm - BMJ medicine, 2023 - ncbi.nlm.nih.gov
Pulmonary hypertension is a progressive and often fatal cardiopulmonary condition
characterised by increased pulmonary arterial pressure, structural changes in the pulmonary …

Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension

MC Van De Veerdonk, JT Marcus, N Westerhof… - Chest, 2015 - Elsevier
BACKGROUND: Even after years of stable response to therapy, patients with idiopathic
pulmonary arterial hypertension (IPAH) may show an unexpected clinical deterioration due …

Therapeutic effects of breviscapine in cardiovascular diseases: a review

J Gao, G Chen, H He, C Liu, X Xiong, J Li… - Frontiers in …, 2017 - frontiersin.org
Breviscapine is a crude extract of several flavonoids of Erigeron breviscapus (Vant.) Hand.-
Mazz., containing more than 85% of scutellarin, which has been traditionally used in China …

Biomechanics of the right ventricle in health and disease (2013 Grover Conference series)

R Naeije, S Brimioulle, L Dewachter - Pulmonary circulation, 2014 - journals.sagepub.com
Right ventricular (RV) function is a major determinant of the symptomatology and outcome in
pulmonary hypertension. The normal RV is a thin-walled flow generator able to …

A miR-208–Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension

R Paulin, G Sutendra, V Gurtu, P Dromparis… - Circulation …, 2015 - Am Heart Assoc
Rationale: Right ventricular (RV) failure is a major cause of morbidity and mortality in
pulmonary hypertension, but its mechanism remains unknown. Myocyte enhancer factor 2 …

Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension

MC van de Veerdonk, JT Marcus… - European …, 2017 - Eur Respiratory Soc
In pulmonary arterial hypertension (PAH), upfront combination therapy is associated with
better clinical outcomes and a greater reduction in N-terminal pro-brain natriuretic peptide …

Melatonin as a preventive and curative therapy against pulmonary hypertension

G Maarman, D Blackhurst, F Thienemann… - Journal of pineal …, 2015 - Wiley Online Library
Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure,
which leads to right ventricular (RV) hypertrophy and failure. The pathophysiological …